Chemokines in oral inflammatory diseases: Apical periodontitis and periodontal disease

Journal of Dental Research

Volumn 86, Issue 4, 2007, Pages 306-319

  Silva, T A ^a   Garlet, G P ^b   Fukada, S Y ^b   Silva, J S ^b   Cunha, F Q ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chemokines; Inflammation; Oral diseases; Periodontitis

Indexed keywords

AUTACOID; CHEMOKINE; CHEMOKINE RECEPTOR;

ANGIOGENESIS; ANIMAL; BONE REMODELING; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; NEUTROPHIL CHEMOTAXIS; PERIODONTITIS; PHYSIOLOGY; REVIEW; TOOTH PERIAPICAL DISEASE;

ANIMALS; BONE REMODELING; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; HUMANS; INFLAMMATION MEDIATORS; NEOVASCULARIZATION, PHYSIOLOGIC; PERIAPICAL PERIODONTITIS; PERIODONTITIS; RECEPTORS, CHEMOKINE;

EID: 34247197984     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910708600403     Document Type: Review

References (173)

1. Abonia JP, Austen KF, Rollins BJ, Joshi SK, Flavell RA, Kuziel WA, et al. (2005). Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2. Blood 105:4308-4313.
2. Attström R (1975). The roles of gingival epithelium and phagocytosing leukocytes in gingival defence. J Clin Periodontol 2:25-32.
3. Bacon K, Baggiolini M, Broxmeyer H, Horuk R, Lindley I, Mantovani A, et al. (2002). Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 22:1067-1068.
4. Baker PJ (2000). The role of immune responses in bone loss during periodontal disease. Microbes Infect 2:1181-1192.
5. Baker PJ, Dixon M, Evans RT, Dufour L, Johnson E, Roopenian DC (1999). CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun 67:2804-2809.
6. Bendre MS, Montague DC, Peery T, Akel NS, Gaddy D, Suva LJ (2003). Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone 33:28-37.
7. Berglundh T, Donati M (2005). Aspects of adaptive host response in periodontitis. J Clin Periodontol 32(Suppl 6):87-107.
8. Berglundh T, Liljenberg B, Tarkowski A, Lindhe J (2002). The presence of local and circulating autoreactive B cells in patients with advanced periodontitis. J Clin Periodontol 29:281-286.
9. Bick PH, Carpenter AB, Holdeman LV, Miller GA, Ranney RR, Palcanis KG, et al. (1981). Polyclonal B-cell activation induced by extracts of Gram-negative bacteria isolated from periodontally diseased sites. Infect Immun 34:43-49.
10. Bischoff DS, Zhu JH, Makhijani NS, Yamaguchi DT (2005). KC chemokine expression by TGF-beta in C3H10T1/2 cells induced towards osteoblasts. Biochem Biophys Res Commun 326:364-370.
11. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, et al. (1998). Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (This) and Th2s. J Exp Med 187:129-134.
12. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, Broxmeyer HE, et al. (1997). Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100:2552-2561.
13. Bowie A, O'Neill LA (2000). Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59:13-23.
14. Boyden S (1962). The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 115:453-466.
15. Boyle WJ, Simonet WS, Lacey DL (2003). Osteoclast differentiation and activation. Nature 423:337-342.
16. Brown CR, Blaho VA, Loiacono CM (2003). Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2. J Immunol 171:893-901.
17. Burger D, Dayer JM (2002). Cytokines, acute-phase proteins, and hormones: IL-1 and TNF-alpha production in contact-mediated activation of monocytes by T lymphocytes. Ann NY Acad Sci 966:464-473.
18. Cacalano G, Lee J, Kikly K, Ryan AM, Pitts-Meek S, Hultgren B, et al. (1994). Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265:682-684.
19. Campbell JJ, Butcher EC (2000). Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 12:336-341.
20. Chae P, Im M, Gibson F, Jiang Y, Graves DT (2002). Mice lacking monocyte chemoattractant protein 1 have enhanced susceptibility to an interstitial polymicrobial infection due to impaired monocyte recruitment. Infect Immun 70:3164-3169.
21. Choi SJ, Cruz JC, Craig F, Chung H, Devlin RD, Roodman GD, et al. (2000). Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood 96:611-615.
22. Cook DN, Beck MA, Coffinan TM, Kirby SL, Sheridan JF, Pragnell IB, et al. (1995). Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269:1583-1585.
23. D'Ambrosio D, Iellem A, Bonecchi R, Mazzeo D, Sozzani S, Mantovani A, et al. (1998). Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 161:5111-5115.
24. Darnell JE Jr, Kerr IM, Stark GR (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
25. Darveau RP, Belton CM, Reife RA, Lamont RJ (1998). Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect Immun 66:1660-1665.
26. de Oliveira Rodini C, Batista AC, Lara VS (2004). Comparative immunohistochemical study of the presence of mast cells in apical granulomas and periapical cysts: possible role of mast cells in the course of human periapical lesions. Oral Surg Oral Med Oral Pathol Oral Radial Endod 97:59-63.
27. Del Fabbro M, Francetti L, Pizzoni L, Weinstein RL (2000). Congenital neutrophil defects and periodontal diseases. Minerva Stomatol 49:293-311.
28. DiPietro LA, Burdick M, Low QE, Kunkel SL, Streiter RM (1998). MIP-1 alpha as a critical macrophage chemoattractant in murine wound repair. J Clin Invest 101:1693-1698.
29. DiPietro LA, Reintjes MG, Low QE, Levi B, Gamelli RL (2001). Modulation of macrophage recruitment into wounds by monocyte chemoattractant protein-1. Wound Repair Regen 9:28-33.
30. Emingil G, Atilla G, Huseyinov A (2004). Gingival crevicular fluid monocyte chemoattractant protein-1 and RANTES levels in patients with generalized aggressive periodontitis. J Clin Periodontol 31:829-834.
31. Emingil G, Atilla G, Baskesen A, Berdeli A (2005). Gingival crevicular fluid EMAP-II, MIP-lalpha and MIP-lbeta levels of patients with periodontal disease. J Clin Periodontol 32:880-885.
32. Esche C, Stellato C, Beck LA (2005). Chemokines: key players in innate and adaptive immunity. J Invest Dermatol 125:615-628.
33. Fitzgerald JE, Kreutzer DL (1995). Localization of interleukin-8 in human gingival tissues. Oral Microbiol Immunol 10:297-303.
34. Fokkema SJ, Loos BG, van der Velden U (2003). Monocyte-derived RANTES is intrinsically elevated in periodontal disease while MCP-1 levels are related to inflammation and are inversely correlated with IL-12 levels. Clin Exp Immunol 131:477-483.
35. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M (1996). A putative chemokine receptor, BLR1, directs B cell migration to defined lyrnphoid organs and specific anatomic compartments of the spleen. Cell 87:1037-1047.
36. Frendeus B, Godaly G, Hang L, Karpman D, Lundstedt AC, Svanborg C (2000). Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J Exp Med 192:881-890.
37. Fritz EA, Jacobs JJ, Giant TT, Roebuck KA (2005). Chemokine IL-8 induction by particulate wear debris in osteoblasts is mediated by NF-kappaB. J Orthop Res 23:1249-1257.
38. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A (2000). Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 71:1535-1545.
39. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A (2001). Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodontal Res 36:194-203.
40. Garlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS (2003). Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 38:210-217.
41. Garlet GP, Martins W Jr, Fonseca BA, Ferreira BR, Silva JS (2004). Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 31:671-679.
42. Garlet GP, Avila-Campos MJ, Milanezi CM, Ferreira BR, Silva JS (2005). Actinobacillus actinomycetemcomitans-induced periodontal disease in mice: patterns of cytokine, chemokine, and chemokine receptor expression and leukocyte migration. Microbes Infect 7:738-747.
43. Garlet GP, Cardoso CR, Silva TA, Ferreira BR, Avila-Campos MJ, Cunha FQ, et al. (2006). Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL and their physiological inhibitors. Oral Microbiol Immunol 21:12-20.
44. Gemmell E, Carter CL, Seymour GJ (2001). Chemokines in human periodontal disease tissues. Clin Exp Immunol 125:134-141.
45. Grassi F, Cristino S, Toneguzzi S, Piacentini A, Facchini A, Lisignoli G (2004). CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. J Cell Physiol 199:244-251.
46. Graves DT, Cochran D (2003). The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontal 74:391-401.
47. Graves DT, Delima AJ, Assuma R, Amar S, Gates T, Cochran D (1998). Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. J Periodontol 69:1419-1425.
48. Graves DT, Jiang Y, Valente AJ (1999). Regulated expression of MCP-1 by osteoblastic cells in vitro and in vivo. Histol Histopathol 14:1347-1354.
49. Gu L, Tseng S, Horner RM, Tarn C, Loda M, Rollins BJ (2000). Control of Th2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404:407-411.
50. Man JH, Choi SJ, Kurihara N, Koide M, Oba Y, Roodman GD (2001). Macrophage inflammatory protein-1 alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood 97:3349-3353.
51. Hanazawa S, Kawata Y, Takeshita A, Kumada H, Okithu M, Tanaka S, et al. (1993). Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues. Infect Immun 61:5219-5224.
52. Hosokawa Y, Nakanishi T, Yamaguchi D, Takahashi K, Yumoto H, Ozaki K, et al. (2002). Macrophage inflammatory protein 3alpha-CC chemokine receptor 6 interactions play an important role in CD4+ T-cell accumulation in periodontal diseased tissue. Clin Exp Immunol 128:548-554.
53. Hosokawa Y, Nakanishi T, Yamaguchi D, Nakae H, Matsuo T (2005a). Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue. Clin Exp Immunol 139:506-512.
54. Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Murakami K, Miyake Y, et al. (2005b). CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease. Clin Exp Immunol 141:467-474.
55. Hou L, Sasaki H, Stashenko P (2000). B-cell deficiency predisposes mice to disseminating anaerobic infections: protection by passive antibody transfer. Infect Immun 68:5645-5651.
56. Huang GT, Haake SK, Park NH (1998). Gingival epithelial cells increase interleukin-8 secretion in response to Actinobacillus actinomycetemcomitans challenge. J Periodontol 69:1105-1110.
57. Huang GT, Potente AP, Kim JW, Chugal N, Zhang X (1999). Increased interleukin-8 expression in inflamed human dental pulps. Oral Surg Oral Med Oral Pathol Oral Radial Endod 88:214-220.
58. Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, et al. (2001). Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. JExp Med 194:847-853.
59. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, et al. (1994). Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci 19:222-227.
60. Izikson L, Klein RS, Charo IF, Weiner HL, Luster AD (2000). Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. JExp Med 192:1075-1080.
61. Jin L, Söder B, Corbel EF (2000). Interleukin-8 and granulocyte elastase in gingival crevicular fluid in relation to periodontopathogens in untreated adult periodontitis. J Periodontol 71:929-939.
62. Kabashima H, Nagata K (2001). Presence of interleukin-4-producing cells for human bone regeneration after application of guided tissue regeneration membranes. J Endod 27:444-448.
63. Kabashima H, Yoneda M, Nagata K, Hirofuji T, Ishihara Y, Yamashita M, et al (2001). The presence of chemokine receptor (CCR5, CXCR3, CCR3)-positive cells and chemokine (MCP1, MIP-1 alpha, MIP-lbeta, IP-10)-positive cells in human periapical granulomas. Cytokine 16:62-66.
64. Kabashima H, Yoneda M, Nagata K, Hiroftiji T, Maeda K (2002). The presence of chemokine (MCP-1, MIP-lalpha, MIP-1beta, IP-10, RANTES)-positive cells and chemokine receptor (CCR5, CXCR3)-positive cells in inflamed human gingival tissues. Cytokine 20:70-77.
65. Kabashima H, Yoneda M, Nakamuta H, Nagata K, Isobe R, Motooka N, et al. (2004). Presence of CXCR3-positive cells and IFN-gamma-producing cells in human periapical granulomas. J Endod 30:634-637.
66. Kaplan G, Luster AD, Hancock G, Cohn ZA (1987). The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses hi human skin. JExp Med 166:1098-1108.
67. Kawai T, Eisen-Lev R, Seki M, Eastcott JW, Wilson ME, Taubman MA (2000). Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol 164:2102-2109.
68. Kawashima N, Stashenko P (1999). Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation. Arch Oral Biol 44:55-66.
69. Kawashima N, Mederman R, Hynes RO, Ulhnann-Cullere M, Stashenko P (1999). Infection-stimulated infraosseus inflammation and bone destruction is increased in P-/E-selectin knockout mice. Immunology 97:117-123.
70. Kim MS, Day CJ, Selinger CI, Magno CL, Stephens SR, Morrison NA (2006a). MCP-1-induced human osteoclast-like cells are tartrateresistant acid phosphatase, NFATcl, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption. J Biol Chem 281:1274-1285.
71. Kim MS, Magno CL, Day CJ, Morrison NA (2006b). Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES. J CellBiochem 97:512-518.
72. Kinane DF, Lappin DF (2001). Clinical, pathological and immunological aspects of periodontal disease. Acta Odontol Scand 59:154-160.
73. Kinane DF, Attström R, European Workshop in Periodontology Group B (2005). Advances in the pathogenesis of periodontitis. Group B consensus report of the fifth European Workshop in Periodontology. J Clin Periodontal 32(Suppl 6): 130-131.
74. Klausen B, Hougen HP, Fiehn NE (1989). Increased periodontal bone loss in temporarily B lymphocyte-deficient rats. J Periodontal Res 24:384-390.
75. Ko HJ, Lim SS (2002). Production of macrophage inflammatory protein (MIP)-lalpha and MIP-1beta by human polymorphonuclear neutrophils stimulated with Porphyromonas endodontalis lipopolysaccharide. J Endod 28:754-757.
76. Kobayashi-Sakamoto M, Isogai E, Hirose K (2003). Porphyromonas gingivalis modulates the production of interleukin 8 and monocyte chemotactic protein 1 in human vascular endothelial cells. Curr Microbiol 46:109-114.
77. Kurihara T, Warr G, Loy J, Bravo R (1997). Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. JExp Med 186:1757-1762.
78. Kwak HB, Lee SW, Jin HM, Ha H, Lee SH, Takeshita S, el al. (2005). Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration. Blood 105:2963-2969.
79. Lean JM, Murphy C, Fuller K, Chambers TJ (2002). CCL9/MIP-1 gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts. J Cell Biochem 87:386-393.
80. Levin LG, Rudd A, Bletsa A, Reisner H (1999). Expression of IL-8 by cells of the odontoblast layer in vitro. Eur J Oral Sci 107:131-137.
81. Lisignoli G, Toneguzzi S, Piacentini A, Cattini L, Lenti A, Tschon M, et al. (2003). Human osteoblasts express functional CXC chemokine receptors 3 and 5: activation by their ligands, CXCL10 and CXCL13, significantly induces alkaline phosphatase and beta-N-acetylhexosaminidase release. J Cell Physiol 194:71-79.
82. Lisignoli G, Cristino S, Toneguzzi S, Grassi F, Piacentini A, Cavallo C, et al. (2004). IL1beta and TNFalpha differently modulate CXCL13 chemokine in stromal cells and osteoblasts isolated from osteoarthritis patients: evidence of changes associated to cell maturation. Exp Gerontol 39:659-665.
83. Lisignoli G, Toneguzzi S, Piacentini A, Cristino S, Grossi F, Cavallo C, et al. (2006). CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients. J Cell Physiol 206:78-85.
84. Lloyd AR, Biragyn A, Johnston JA, Taub DD, Xu L, Michiel D, et al. (1995). Granulocyte-colony stimulating factor and lipopolysaccharide regulate the expression of interleukin 8 receptors on polymorphonuclear leukocytes. J Biol Chem 270:28188-28192.
85. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C, et al. (1998). CCR5 is characteristic of Th1 lymphocytes. Nature 391:344-345.
86. Loetscher P, Pellegrino A, Gong JH, Mattioli I, Loetscher M, Bardi G, et al. (2001). The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. JBiol Chem 276:2986-2991.
87. Low QE, Drugea IA, Dufrher LA, Quinn DG, Cook DN, Rollins BJ, et al. (2001). Wound healing in MIP-lalpha(-/-) and MCP(-/-) mice. Am J Pathol 159:457-463.
88. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, et al. (1998). Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187:601-608.
89. Ma J, Chen T, Mandelin J, Ceponis A, Miller NE, Hukkanen M, et al. (2003). Regulation of macrophage activation. Cell Mol Life Sci 60:2334-2346.
90. Madianos PN, Papapanou PN, Sandros J (1997). Porphyromonas gingivalis infection of oral epithelium inhibits neutrophil transepithelial migration. Infect Immun 65:3983-3990.
91. Madianos PN, Bobetsis YA, Kinane DF (2005). Generation of inflammatory stimuli: how bacteria set up inflammatory responses in the gingiva. J Clin Periodontol 32(Suppl 6):57-71.
92. Marriott I (2004). Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression. Immunol Res 30:291-308.
93. Marriott I, Gray DL, Rati DM, Fowler VG Jr, Stryjewski ME, Levin LS, et al. (2005). Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. Bone 37:504-512.
94. Marton IJ, Rot A, Schwarzinger E, Szakall S, Radies T, Valyi-Nagy I, et al. (2000). Differential in situ distribution of interleukin-8, monocyte chemoattractant protein-1 and RANTES in human chronic periapical granuloma. Oral Microbiol Immunol 15:63-65.
95. Mathur A, Michalowicz B, Castillo M, Aeppli D (1996). Interleukin-1 alpha, interleukin-8 and interferon-alpha levels in gingival crevicular fluid. J Periodontal Res 31:489-495.
96. Matsushita K, Tajima T, Tomita K, Takada H, Nagaoka S, Torii M (1999). Inflammatory cytokine production and specific antibody responses to lipopolysaccharide from endodontopathic black-pigmented bacteria in patients with multilesional periapical periodontitis. J Endod 25:795-799.
97. McGrory K, Flaitz CM, Klein JR (2004). Chemokine changes during oral wound healing. Biochem Biophys Res Commun 324:317-320.
98. Menzies-Gow A, Ying S, Sabroe I, Stubbs VL, Soler D, Williams TJ, et al. (2002). Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol 169:2712-2718.
99. Miller CG, Cook DN, Kotwal GJ (1996). Two chemotactic factors, C5a and MIP-1 alpha, dramatically alter the mortality from zymosan-induced multiple organ dysfunction syndrome (MODS): C5a contributes to MODS while MIP-1 alpha has a protective role. Mol Immunol 33:1135-1137.
100. Miyauchi M, Kitagawa S, Hiraoka M, Saito A, Sato S, Kudo Y, et al. (2004). Immunolocalization of CXC chemokine and recruitment of polymorphonuclear leukocytes in the rat molar periodontal tissue after topical application of lipopolysaccharide. Histochem Cell Biol 121:291-297.
101. Moser B, Loetscher P (2001). Lymphocyte traffic control by chemokines. Nat Immunol 2:123-128.
102. Moser B, Wolf M, Walz A, Loetscher P (2004). Chemokines: multiple levels of leukocyte migration control. Trends Immunol 25:75-84.
103. Murakami Y, Hanazawa S, Tanaka S, Iwahashi H, Yamamoto Y, Fujisawa S (2001). A possible mechanism of maxillofacial abscess formation: involvement of Porphyromonas endodontalis lipopolysaccharide via the expression of inflammatory cytokines. Oral Microbiol Immunol 16:321-325.
104. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, et al. (2000). International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52:145-176.
105. Nagaoka S, Tokuda M, Sakuta T, Taketoshi Y, Tamura M, Takada H, et al. (1996). Interleukin-8 gene expression by human dental pulp fibroblast in cultures stimulated with Prevotella intermedia lipopolysaccharide. J Endod 22:9-12.
106. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, et al. (1996). Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635-638.
107. Nair PN (1997). Apical periodontitis: a dynamic encounter between root canal infection and host response. Periodontol 2000 13:121-148.
108. Nair PN (2004). Pathogenesis of apical periodontitis and the causes of endodontic failures. Crit Rev Oral Biol Med 15:348-381.
109. Nakajima T, Ueki-Maruyama K, Oda T, Ohsawa Y, Ito H, Seymour GJ, et al. (2005). Regulatory T-cells infiltrate periodontal disease tissues. J Dent Res 84:639-643.
110. Nakanishi T, Takahashi K, Hosokawa Y, Adachi T, Nakae H, Matsuo T (2005). Expression of macrophage inflammatory protein3alpha in human inflamed dental pulp tissue. J Endod 31:84-87.
111. Ohguchi Y, Ishihara Y, Ohguchi M, Koide M, Shirozu N, Naganawa T, et al. (2003). Capsular polysaccharide from Actinobacillus actinomycetemcomitans inhibits IL-6 and IL-8 production in human gingival fibroblast. J Periodontal Res 38:191-197.
112. Okamatsu Y, Kim D, Battaglino R, Sasaki H, Spate U, Stashenko P (2004). MIP-1 gamma promotes receptor-activator-of-NF-kappa-B-ligand-induced osteoclast formation and survival. J Immunol 173:2084-2090.
113. Onoe Y, Miyaura C, Kaminakayashiki T, Nagai Y, Noguchi K, Chen QR, et al. (1996). IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. J Immunol 156:758-764.
114. Park SH, Hsiao GY, Huang GT (2004). Role of substance P and calcitonin gene-related peptide in the regulation of interleukin-8 and monocyte chemotactic protein-1 expression in human dental pulp. Int Endod J 37:185-192.
115. Patel T, Park SH, Lin LM, Chiappelli F, Huang GT (2003). Substance P induces interleukin-8 secretion from human dental pulp cells. Oral Surg Oral Med Oral Pathol Oral Radial Endod 96:478-485.
116. Payne JB, Reinhardt RA, Masada MP, DuBois LM, Allison AC (1993). Gingival crevicular fluid IL-8: correlation with local IL-1 beta levels and patient estrogen status. J Periodontal Res 28:451-453.
117. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB (2004). Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22:929-979.
118. Rahimi P, Wang CY, Stashenko P, Lee SK, Lorenzo JA, Graves DT (1995). Monocyte chemoattractant protein-1 expression and monocyte recruitment in osseous inflammation in the mouse. Endocrinology 136:2752-2759.
119. Reinhardt RA, Bolton RW, McDonald TL, DuBois LM, Kaldahl WB (1988). In situ lymphocyte subpopulations from active versus stable periodontal sites. J Periodontol 59:656-670.
120. Rhodus NL, Cheng B, Myers S, Bowles W, Ho V, Ondrey F (2005). A comparison of the pro-inflammatory, NF-kappaB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol 114:278-283.
121. Rodan GA, Martin TJ (2000). Therapeutic approaches to bone diseases. Science 289:1508-1514.
122. + T cells in human granulomas and periapical cysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:221-227.
123. Romas E, Sims NA, Hards DK, Lindsay M, Quinn JW, Ryan PF, et al. (2002). Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. Am J Pathol 161:1419-1427.
124. Rosenkilde MM, Schwartz TW (2004). The chemokine system - a major regulator of angiogenesis in health and disease. APMIS 112:481-495.
125. Rossi D, Zlotnik A (2000). The biology of chemokines and their receptors. Annu Rev Immunol 18:217-242.
126. Rot A, von Andrian UH (2004). Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22:891-928.
127. Ruddy MJ, Shen F, Smith JB, Sharma A, Gaffen SL (2004). Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol 76:135-144.
128. Sallusto F, Lanzavecchia A, Mackay CR (1998a). Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19:568-574.
129. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A (1998b). Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187:875-883.
130. Sallusto F, Mackay CR, Lanzavecchia A (2000). The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 18:593-620.
131. Sasaki H, Hou L, Belani A, Wang CY, Uchiyama T, Muller R, et al. (2000). IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo. J Immunol 165:3626-3630.
132. Scheven BA, Milne JS, Hunter I, Robins SP (1999). Macrophage-inflammatory protein-1 alpha regulates preosteoclast differentiation in vitro. Biochem Biophys Res Commun 254:773-778.
133. Schmalz G, Schweikl H, Hiller KA (2000). Release of prostaglandin E2, IL-6 and IL-8 from human oral epithelial culture models after exposure to compounds of dental materials. Ear J Oral Sci 108:442-448.
134. Schofield DA, Westwater C, Warner T, Balish E (2005). Differential Candida albicans lipase gene expression during alimentary tract colonization and infection. FEMS Microbiol Lett 244:359-365.
135. Schroder JM (2000). Chemoattractants as mediators of neutrophilic tissue recruitment. Clin Dermatol 18:245-263.
136. Segovia-Juarez JL, Ganguli S, Kirschner D (2004). Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model. J Theor Biol 231:357-376.
137. Seymour GJ, Powell RN, Davies WI (1979). Conversion of a stable T-cell lesion to a progressive B-cell lesion in the pathogenesis of chronic inflammatory periodontal disease: an hypothesis. J Clin Periodontol 6:267-277.
138. Shimauchi H, Takayama S, Narikawa-Kiji M, Shimabukuro Y, Okada H (2001). Production of interleukin-8 and nitric oxide in human periapical lesions. J Endod 27:749-752.
139. Sica A, Saccani A, Borsatti A, Power CA, Wells TN, Luini W, et al. (1997). Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med 185:969-974.
140. Silva TA, Lara VS, Rosa AL, Cunha FQ (2004a). Cytokine and chemokine response of bone cells after dentin challenge in vitro. Oral Dis 10:258-264.
141. Silva TA, Lara VS, Silva JS, Garlet GP, Butler WT, Cunha FQ (2004b). Dentin sialoprotein and phosphoprotein induce neutrophil recruitment: a mechanism dependent on IL-1beta, TNF-beta, and CXC chemokines. Calcif Tissue Int 74:532-541.
142. Silva TA, Garlet GP, Lara VS, Martins W Jr, Silva JS, Cunha FQ (2005). Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases. Oral Microbiol Immunol 20:310-316.
143. Sitia G, Isogawa M, Kakimi K, Wieland SF, Chisari FV, Guidotti LG (2002). Depletion of neutrophils blocks the recruitment of antigennonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes. Proc Natl Acad Sci USA 99:13717-13722.
144. Sozzani S, Ghezzi S, lannolo G, Luini W, Borsatti A, Pollentarutti N, et al. (1998). Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med 187:439-444.
145. Stricter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, et al. (1995). The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270:27348-27357.
146. Takashiba S, Takigawa M, Takahashi K, Myokai F, Nishimura F, Chihara T, et al. (1992). Interleukin-8 is a major neutrophil chemotactic factor derived from cultured human gingival fibroblasts stimulated with interleukin-1 beta or tumor necrosis factor alpha. Infect Immun 60:5253-5258.
147. Takigawa M, Takashiba S, Myokai F, Takahashi K, Arai H, Kurihara H, et al. (1994). Cytokine-dependent synergistic regulation of interleukin-8 production from human gingival fibroblasts. J Periodontol 65:1002-1007.
148. Teles R, Wang CY, Stashenko P (1997). Increased susceptibility of RAG-2 SCID mice to dissemination of endodontic infections. Infect Immun 65:3781-3787.
149. Terricabras E, Benjamim C, Godessart N (2004). Drug discovery and chemokine receptor antagonists: eppur si muove! Autoimmun Rev 3:550-556.
150. Tessier PA, Naccache PH, dark-Lewis I, Gladue RP, Neote KS, McColl SR (1997). Chemokine networks in vivo: involvement of both C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J Immunol 159:3595-3602.
151. Tonetti MS, Imboden MA, Gerber L, Lang NP, Laissue J, Mueller C (1994). Localized expression of mRNA for phagocyte-specific chemotactic cytokines in human periodontal infections. Infect Immun 62:4005-4014.
152. Tsai CC, Ho YP, Chen CC (1995). Levels of interleukin-1 beta and interleukin-8 in gingival crevicular fluids in adult periodontitis. J Periodontol 66:852-859.
153. Tuncer BB, Ozmeric N, Tuncer C, Teoman I, Cakilci B, Yucel A, et al. (2005). Levels of interleukin-8 during tooth movement. Angle Orthod 75:631-636.
154. Votta BJ, White JR, Dodds RA, James IE, Connor JR, Lee-Rykaczewski E, et al. (2000). Ckbeta-8 (CCL23), a novel CC chemokine, is chemotactic for human osteoclast precursors and is expressed in bone tissues. J Cell Physiol 183:196-207.
155. Waddington RJ, Moseley R, Embery G (2000). Reactive oxygen species: a potential role in the pathogenesis of periodontal diseases. Oral Dis 6:138-151.
156. Watanabe T, Kukita T, Kukita A, Wada N, Toh K, Nagata K, et al. (2004). Direct stimulation of osteoclastogenesis by MIP-1 alpha: evidence obtained from studies using RAW264 cell clone highly responsive to RANKL. J Endocrinol 180:193-201.
157. Wiebe SH, Hafezi M, Sandhu HS, Sims SM, Dixon SJ (1996). Osteoclast activation in inflammatory periodontal diseases. Oral Dis 2:167-180.
158. Wise GE, Que BG, Huang H (1999). Synthesis and secretion of MCP-1 by dental follicle cells - implications for tooth eruption. J Dent Res 78:1677-1681.
159. Wright KM, Friedland JS (2004). Regulation of chemokine gene expression and secretion in Staphylococcus aureus-infected osteoblasts. Microbes Infect 6:844-852.
160. Wright LM, Maloney W, Yu X, Kindle L, Collin-Osdoby P, Osdoby P (2005). Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. Bone 36:840-853.
161. Yamamoto M, Kawabata K, Fujihashi K, McGhee JR, Van Dyke TE, Bamberg TV, et al. (1996). Absence of exogenous interleukin-4-induced apoptosis of gingival macrophages may contribute to chronic inflammation in periodontal diseases. Am J Pathol 148:331-339.
162. Yamasaki M, Kumazawa M, Kohsaka T, Nakamura H (1994). Effect of methotrexate-induced neutropenia on rat periapical lesion. Oral Surg Oral Med Oral Pathol 77:655-661.
163. Yang LC, Huang FM, Lin CS, Liu CM, Lai CC, Chang YC (2003). Induction of interleukin-8 gene expression by black-pigmented Bacteroides in human pulp fibroblasts and osteoblasts. Int Endod J 36:774-779.
164. Yang M, Mailhot G, MacKay CA, Mason-Savas A, Aubin J, Odgren PR (2006). Chemokine and chemokine receptor expression during colony stimulating factor-1-induced osteoclast differentiation in the toothless osteopetrotic rat: a key role for CCL9 (MIP-1 gamma) in osteoclastogenesis in vivo and in vitro. Blood 107:2262-2270.
165. Yano S, Mentaverri R, Kanuparthi D, Bandyopadhyay S, Rivera A, Brown EM, et al. (2005). Functional expression of beta-chemokine receptors in osteoblasts: role of regulated upon activation, normal T cell expressed and secreted (RANTES) in osteoblasts and regulation of its secretion by osteoblasts and osteoclasts. Endocrinology 146:2324-2335.
166. Yoshie H, Taubman MA, Ebersole JL, Olson CL, Smith DJ, Pappo J (1985). Activation of rat B lymphocytes by Actinobacillus actinomycetemcomitans. Infect Immun 47:264-270.
167. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, et al. (1987). Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84:9233-9237.
168. Yu X, Graves DT (1995). Fibroblasts, mononuclear phagocytes, and endothelial cells express monocyte chemoattractant protein-1 (MCP-1) in inflamed human gingiva. J Periodontol 66:80-88.
169. Yu X, Huang Y, Collin-Osdoby P, Osdoby P (2004). CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J Bone Miner Res 19:2065-2077.
170. Yumoto H, Nakae H, Fujinaka K, Ebisu S, Matsuo T (1999). Interleukin-6 (IL-6) and IL-8 are induced in human oral epithelial cells in response to exposure to periodontopathic Eikenella corrodens. Infect Immun 67:384-394.
171. Zhang J, Kashket S, Lingström P (2002). Evidence for the early onset of gingival inflammation following short-term plaque accumulation. J Clin Periodontol 29:1082-1085.
172. Zhang XW, Wang Y, Liu Q, Thorlacius H (2001). Redundant function of macrophage inflammatory protein-2 and KC in tumor necrosis factor-alpha-induced extravasation of neutrophils in vivo. Eur J Pharmacol 427:277-283.
173. Zlotnik A, Yoshie O (2000). Chemokines: a new classification system and their role in immunity. Immunity 12:121-127.